Angiotensin receptor blockers and endpoint protection

Blood Press. 2005;14(4):195. doi: 10.1080/08037050500224006.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Hydrochlorothiazide / therapeutic use
  • Hypertrophy, Left Ventricular / drug therapy
  • Vascular Resistance / drug effects

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Hydrochlorothiazide